Chorionic Villus Sampling (CVS)
Chorionic Villus Sampling (CVS) is a prenatal test that involves taking a small sample of tissue from the placenta, which is the organ that nourishes a developing fetus. This tissue is called chorionic villi and contains genetic material. CVS is typically performed between the 10th and 13th weeks of pregnancy. It can help identify genetic disorders, chromosomal abnormalities, and certain inherited conditions early in pregnancy. The procedure can be done through the cervix (transcervical) or the abdomen (transabdominal), and while it carries some risks, it can provide valuable information for expectant parents.
Additional Insights
-
Chorionic villus sampling (CVS) is a prenatal test that helps detect genetic disorders in a developing fetus. It involves taking a small sample of tissue from the placenta, which shares the baby's genes. This sample is usually collected through the cervix or abdomen, typically between the 10th and 13th weeks of pregnancy. CVS can identify conditions like Down syndrome or cystic fibrosis. The procedure carries some risks, including miscarriage, so it is usually recommended for women with specific risk factors. Results are usually available within a week, allowing parents to make informed decisions about their pregnancy.
-
Chorionic villus sampling (CVS) is a prenatal test used to assess the genetic health of a developing fetus. It involves taking a small sample of tissue from the placenta, which shares the fetus's genetic material. This is typically done between the 10th and 13th weeks of pregnancy. The sample is analyzed for chromosomal abnormalities, like Down syndrome, and other genetic disorders. CVS can provide results earlier than amniocentesis but carries a small risk of miscarriage. It's important for expectant parents to discuss the benefits and risks with their healthcare provider.